2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults

Autor:	G.B. John Mancini, Eileen O’Meara, Shelley Zieroth, Mathieu Bernier, Alice Y.Y. Cheng, David Z.I. Cherney, Kim A. Connelly, Justin Ezekowitz, Ronald M. Goldenberg, Lawrence A. Leiter, Gihad Nesrallah, Breay W. Paty, Marie-Eve Piché, Peter Senior, Abhinav Sharma, Subodh Verma, Vincent Woo, Pol Darras, Jonathan Y. Gabor, Jean Grégoire, Eva Lonn, James A. Stone, Jean-François Yale, Colin Yeung, Deborah Zimmerman
Rok vydání:	2022
Předmět:	Cardiology and Cardiovascular Medicine
Zdroj:	Canadian Journal of Cardiology. 38:1153-1167
ISSN:	0828-282X
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::becbdc851e8a2ee4e52397bc3ee7d3fa https://doi.org/10.1016/j.cjca.2022.04.029 Zobrazit plný text záznamu Full Text from ScienceDirect